April 28, 2020 / 9:23 PM / a month ago

BRIEF-Vistagen Therapeutics Inc - Expands Ph94b Clinical Development To Include Adjustment Disorder Related To Covid-19

April 28 (Reuters) - VistaGen Therapeutics Inc:

* VISTAGEN THERAPEUTICS INC - EXPANDS PH94B CLINICAL DEVELOPMENT TO INCLUDE ADJUSTMENT DISORDER RELATED TO COVID-19

* VISTAGEN THERAPEUTICS - TO SUBMIT PROPOSED PROTOCOL FOR A PHASE 2 STUDY OF PH94B FDA THROUGH FDA’S NEW CORONAVIRUS TREATMENT ACCELERATION PROGRAM

* VISTAGEN THERAPEUTICS INC - CURRENTLY PREPARING FOR PHASE 3 DEVELOPMENT OF PH94B FOR TREATMENT OF SOCIAL ANXIETY DISORDER Source text for Eikon: bit.ly/3bNAeIW Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below